TAICHU BIOTECHNOLOGY
Taichu Biotechnology offers customized CRO+CDMO technical services for single and combined business sectors for the development and manufacturing of various novel pharmaceuticals.
TAICHU BIOTECHNOLOGY
Industry:
Medical Pharmaceutical Product Research
Founded:
2020-01-01
Address:
Shanghai, Shanghai, China
Country:
China
Website Url:
http://www.taichubio.com
Status:
Active
Total Funding:
299 M CNY
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
CStone Pharmaceuticals
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
dMed
dMed is a full-service Clinical Contract Research Organization that provides industry solutions to pharma and medical device companies.
Hua Medicine
Hua Medicine is a clinical-stage, innovative drug development company in China.
Structure Therapeutics
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Verismo Therapeutics
Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.
Investors List
Chip Aviation Capital
Chip Aviation Capital investment in Series A - Taichu Biotechnology
Shenzhen Juntong Capital Investment Management
Shenzhen Juntong Capital Investment Management investment in Series A - Taichu Biotechnology
Yijing Capital
Yijing Capital investment in Series A - Taichu Biotechnology
Aopeng Investment
Aopeng Investment investment in Series A - Taichu Biotechnology
Season Venture Capital
Season Venture Capital investment in Series A - Taichu Biotechnology
Lula Capital
Lula Capital investment in Series A - Taichu Biotechnology
IDG Capital
IDG Capital investment in Series A - Taichu Biotechnology
Boquan Capital
Boquan Capital investment in Series A - Taichu Biotechnology
Shanghai Kechuang Jijin
Shanghai Kechuang Jijin investment in Series A - Taichu Biotechnology
Shanghai Biomedical Industrial Equity Investment Fund
Shanghai Biomedical Industrial Equity Investment Fund investment in Series A - Taichu Biotechnology
Official Site Inspections
http://www.taichubio.com Semrush global rank: 14.05 M Semrush visits lastest month: 63
- Host name: catl.com
- IP address: 203.107.45.167
- Location: Hangzhou China
- Latitude: 30.294
- Longitude: 120.1619
- Timezone: Asia/Shanghai
More informations about "Taichu Biotechnology"
泰楚生物集团-创新驱动型新药非临床研发全产业链特色服务平台
Mouse slide Taichu Biotechnology Innovative Drug Non Clinical Research and Service Platform (CRO) Taichu Biotechnology , founded in October 2020, is a contract research organization …See details»
泰楚生物集团-创新驱动型新药非临床研发全产业链特色服务平台
泰楚生物成立于2020年10月，位于上海临港新片区生命蓝湾，是一家聚焦于创新药非临床研究与服务的合同研究组织（CRO）。See details»
About us - taichubio.com
01 Enterprise Spirit Advocating quality, team writing, willing to contribute, and putting people first Enterprise Spirit Advocate for quality: Quality is the foundation of survival, and quality is the source of benefits Unity and collaboration: …See details»
Taichu Biotechnology - Crunchbase Company Profile
Taichu Biotechnology offers customized CRO+CDMO technical services for single and combined business sectors for the development and manufacturing …See details»
Taichu Biotechnology Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, cap tables, investors, and executives for Taichu Biotechnology. Use the PitchBook Platform to explore the full profile.See details»
Taichu Bio - CB Insights
Taichu Bio is a contract research organization (CRO). It provides non-clinical drug evaluation of biopharmaceuticals, antibody drug development and production, chemical drug preparation …See details»
Tai Chu Bio - VentureRadar
Preclina South Korea n/a Preclina is a specialized non-clinical contract research organization (CRO) offering a fully-integrated drug discovery platform with a focus on autoimmune …See details»
Shanghai Taizhen Biotechnology Co., Ltd. (Shanghai Taizhen ...
地址：中国上海临港新片区平达路308号 邮箱：[email protected] 网址：www.taichubio.com 电话：021-80403636 关于泰楚（深圳） 泰楚（深圳）生物技术有限公 …See details»
Shanghai Taichu Biotechnology Co., Ltd. - Patsnap
Explore Shanghai Taichu Biotechnology Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
关于我们-泰楚集团 - taichubio.com
刘洵 博士 集团 总经理 刘洵 博士 集团 总经理 毕业于北京大学化学系，获得学士学位，之后在美国罗格斯大学获得博士学位，之后进入麻省理工学院（MIT），师从诺贝尔奖获奖者Gobind …See details»
Taichu Biotech - Owler
Taichu Biotech’s Profile, Revenue and Employees. Taichu Biotech is a China-based CRO that provides drug development and evaluation services for the biopharmaceutical industry.See details»
Shanghai Taichu Biotechnology Co., Ltd. - 药物管线_专利_临床试 …
了解Shanghai Taichu Biotechnology Co., Ltd.公司的药物管线，治疗领域，技术平台，以及它的105篇新闻。See details»
Shanghai Taichu Biotechnology Co., Ltd. - synapse.zhihuiya.com
了解Shanghai Taichu Biotechnology Co., Ltd. (上海泰楚生物技术有限公司)公司的药物管线，治疗领域，技术平台，以及它的262篇新闻。See details»
Taichu (Shenzhen) - taichubio.com
Taichu Biotechnology Innovative Drug Non Clinical Research and Service Platform (CRO) AceMab AceMouse ™- The most perfect antibody fully humanized mouse platform (CRO) …See details»
Tai Chu Bio - Company Profile - Tracxn
Dec 2, 2024 Tai Chu Bio - CRO focused on non-clinical research, drugs screening, and pharmacokinetics services. Raised funding from 1 investor.See details»
泰楚生物-动脉网 - vbdata.cn
上海泰楚生物技术有限公司是一家专注于医药CRDMO服务，为各类新药研发和生产提供一站式研发及生产服务的大型集团式企业。宜明细胞深耕CGT领域数十年，依托一站式CDMO服务平 …See details»
【首发】 泰楚生物完成近4亿元A轮融资，加快新药CRO+CDMO定 …
May 8, 2023 动脉网第一时间获悉，上海泰楚生物技术有限公司（简称：泰楚生物）完成A轮融资，融资总额近4亿元人民币。本轮融资由IDG资本领投，业界知名投资机构上海科创基金、君 …See details»
Group dynamics - taichubio.com
The development, application, and production process of antibody drugs are accompanied by quality research and control of products. The quality analysis of antibody drugs involves …See details»
写意会员 | 泰楚生物：崇德求真，成就客户 - 搜狐
Mar 30, 2023 在加入生物医药行业前，曾在全球生命科学领军企业任职8年，作为中国区管理层，先后担任服务运营高级总监、商务运营副总裁职务，成功实现庞大运营团队的整合及商务市 …See details»
Media report - taichubio.com
The 62nd Annual Toxicology Conference of the United States in 2023 was held from March 19 to 23 in Nashville, Tennessee, USA. The conference attracted more than 250 exhibitors, …See details»